selective covalent Pin1 inhibitor

oral efficacy in xenograft model

from covalent fragment screen and opt.

bioRxiv, Mar. 21, 2020

Weizmann Institute / Harvard Medical

Sulfopin

Sulfopin (Weizmann/Harvard selective covalent Pin1 inhibitor)


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: